Stand out for this role — generate a tailored resume and cover letter in about a minute.
CTIBIOTECH USA in Philadelphia seeks a Senior Research Scientist to lead technology transfer of proprietary tissue engineering and bio-ink protocols into US production pipelines. You will oversee a high-throughput lab and validate research workflows for commercial contracts.
The ideal candidate has a PhD or equivalent, 5+ years in leadership within biotech, and deep expertise in 3D bioprinting, primary human cell expansion, and genomic analyses, enabling rigorous data integrity and translational
You are viewing a preview of this job. Log in or register to view more details about this job.
NOTE, we cannot sponsor visas on this job application.
Senior Research Scientist
Location: Philadelphia, PA (BioLabs Hub)Target Start Date: September 2026 (Adjusted Schedule)Compensation Range: $100,000 – $115,000 / yearCompany & Platform OverviewAbout CTIBIOTECH USA (Preclinical CRDMO): CTIBIOTECH USA, a Philadelphia-based biotech company, is a rapidly scaling Precision Medicine CRDMO. Our unique \"Hybrid Engine\" model bridges the gap between passive bio-storage and predictive medical science. By combining GenVault's world-class, GxP-compliant biorepository logistics with CTIBIOTECH's industrialized tissue engineering, we monetize the entire lifecycle of a biological sample. Through our core Preclinical CRDMO pillars—CTIBioSourcing™, CTISkin™, and CTIPharma™—we generate immediate cash flow and serve as a trusted R&D partner to global pharmaceutical leaders.
About the CTIONCOTEST™ Project: CTIONCOTEST™ is our proprietary precision medicine platform and core valuation driver. It directly solves the critical 95% failure rate in oncology clinical trials caused by inaccurate animal models. Utilizing industrialized 3D-bioprinting and proprietary bio-inks, the platform dissociates a live patient tumor biopsy and re-assembles it into hundreds of identical, reproducible \"3D micro-tumors\" that perfectly mimic the human tumor microenvironment. CTIONCOTEST™ commercialization is built on three pillars: Laboratory Developed Tests (LDT), Companion Diagnostics (CDx), and Oncology CRO Services.
As our foundational scientific leader in Philadelphia, the Lead R&D Manager will spearhead the technical transfer and translation of our proprietary tissue engineering and bio-ink protocols from our global technology base into active US production pipelines. You will lead a high-throughput laboratory, driving internal assay innovation and validating custom research workflows for commercial contracts.